By Hoopesvision on March 4, 2014
This past Friday, Dr. Phillip Hoopes Jr., surgeon at Hoopes Vision and medical director of EyeSurg of Utah, was a speaker at the Utah Ophthalmology Society’s yearly winter meeting. He presented the results of Hoopes Vision’s cataract laser comparison study to the many ophthalmologists in attendance.
Laser-assisted cataract surgery is the most exciting new development in cataract surgery in decades, promising unprecedented speed, precision, and safety. Hoopes Vision acquired the Alcon LenSx® cataract laser in October 2011, making us among the first surgical centers in the United States to do so. When we acquired the Optimedica Catalys™ Precision Laser System in July 2012, we became the first surgery center in the world to own multiple cataract laser platforms.
(L) The Optimedica Catalys (foreground) and Alcon LenSx cataract lasers; (R) Dr. Phillip C. Hoopes, Jr.
This placed Hoopes Vision in the unique position of being able to compare performance and results side-by-side, which we took advantage of by launching a comparison study of the two lasers. That study, which began in late 2012 and continued through most of last year, tracked the surgeons’ experiences as well as the patients’ outcomes for 100 laser-assisted cataract procedures wherein the study patients had surgery in one eye with the assistance of the LenSx, and the other eye using the Catalys. The results of the study, as presented by Dr. Hoopes Jr. this past weekend showed the differences in performance and results between the two lasers. This information will be invaluable when deciding which of these lasers our practice will keep.
Since the beginning, Hoopes Vision’s goal has always been to represent the newest, safest, most innovative vision correction technology, and to offer our patients that technology in the hands of experienced, caring surgeons and staff. Our early adoption of laser cataract surgery is just one of the many examples of that ongoing commitment.
By Hoopesvision on January 21, 2014
Hundreds of thousands of Americans, and millions worldwide, suffer from keratoconus, a degenerative disorder of the eye in which the cornea (the clear tissue at the front of the eye, through which we see) becomes thin and distorted, changing from its natural round shape into the cone-like shape from which the condition gets its name. As the condition progresses and the cornea becomes increasingly thin and distorted, patients begin to experience vision problems such as glare from light sources, rapid changes in eyeglass prescription, and double or multiple images.
The extent to which keratoconus progresses, and the speed with which it does so, varies from patient to patient. In many cases, progress is slow enough, or stops early enough, that good vision can be maintained with glasses or contact lenses, often gas permeable hard contacts that physically help the cornea to hold its shape. Some patients require corneal ring inlays such as INTACS™, small clear plastic inserts that are surgically placed into the corneal tissue itself, to slow the progress of the disease. In other cases, however, the condition continues to progress to the point that good vision is no longer possible with corrective lenses, and in some rare cases it can progress to the point that the thinning corneal tissue becomes painful and at risk for rupture.
For decades, the final option to restore vision and comfort in these extreme cases was corneal transplantation, where the patient’s central cornea was surgically removed and replaced with an identically sized piece of tissue from a donor cornea, which was then sutured into place. Thousands of these procedures are performed every year, bringing improved vision and quality of life to keratoconus patients. However, the recovery can be long, there is a possibility that the patient’s body may reject the tissue graft (though the risk of rejection for a cornea transplant is very low compared to most other transplant procedures), and donor tissue is often in short supply.
Within the past decade or so – only since 2008 in the United States – a new technique has been gaining in popularity. Corneal collagen crosslinking, often abbreviated to CXL, is a non-surgical, non-invasive procedure in which riboflavin (Vitamin B2) and an ultraviolet light source are used to treat keratoconus. Application of riboflavin and subsequent exposure to UV light (in a controlled clinical environment) cause new links to form between the collagen strands in the cornea, strengthening the tissue and slowing or even halting the progression of keratoconus. Thus far, in patients who are good candidates for the procedure, CXL has proven to be very effective in treating patients who would otherwise have needed corneal transplants.
The Department of Clinical Research at Hoopes Vision’s facility in Draper, Utah has been taking part in a clinical trial of a new corneal crosslinking procedure, the KXL Accelerated Corneal Crosslinking System by Avedro. This system differs from earlier crosslinking systems in that the patient’s UV exposure time is only three minutes per eye, compared to 30 minutes or more per eye for previous systems, time during which the patient would be sitting or lying down with the eye held open. The far shorter treatment time leads to a more pleasant, comfortable patient experience, while still achieving the same remarkable result in slowing or stopping the progression of keratoconus. Hoopes Vision will shortly be offering this new treatment for keratoconus patients.
By Hoopesvision on January 14, 2014
Nearly two decades after its introduction, LASIK has become one of the most common and well-known elective surgeries in the world, with millions of people having achieved great vision by means of this quick, comfortable outpatient procedure. Most people have heard of LASIK, and are aware that it’s a laser vision correction procedure. Many people know someone who has had LASIK, someone who wore glasses, reading glasses, or contact lenses – then, suddenly, didn’t need them anymore!
But many people may ask themselves, “Can LASIK help me?”
The only way to be completely sure of whether or not you are a candidate for LASIK is to have a screening examination at a clinic specializing in vision correction surgery. There is testing that must be performed, including detailed maps and measurements of the eye that are beyond the scope of a routine eye exam, and those test results should be interpreted by a doctor who is experienced in LASIK. However, the list below is a good start for anyone thinking about vision correction surgery who might be wondering “Who can have LASIK?”
A great LASIK candidate:
- Is at least 18 years of age.
- Needs glasses and/or contact lenses to see better, due to myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and/or presbyopia (difficulty seeing up close due to “after 40 vision”).
- Wants to be able to read, drive, play sports, and engage in other daily activities, free from corrective lenses.
- Has had a stable prescription for at least the last year. (This can be determined by checking the patient’s current prescription, and comparing it to the most recent eyeglass or contact lens prescription.)
- Has healthy, regularly shaped corneas, with adequate tissue thickness. (This is measured in the LASIK screening examination.)
These factors may make a patient a poor candidate for LASIK:
- Presence of a visually or clinically significant cataract.
- Extremely high myopic (worse than -12.00), hyperopic (worse than +4.00), or astigmatic (more than -4.00 diopter) prescriptions.
- Poorly managed diabetes, which can impact healing and cause other vision problems.
- Very thin or irregularly shaped corneas.
- Severely dry eyes, including the kind of dry eyes caused by certain autoimmune disorders.
- Pregnancy. (You can have babies after you have LASIK, and you can have LASIK after you have babies; you just can’t have it while you are actually pregnant!)
Note that some of those factors are not automatic disqualifiers, but simply things that the surgeon and patient must consider when determining the best option for vision correction, and even those patients who are not ideal candidates for LASIK may still be able to achieve great vision with other kinds of surgery. For example, patients whose corneas are too thin or irregularly shaped for LASIK may obtain a great result with PRK, a similar laser procedure that achieves equally excellent long-term vision, but has a slightly longer healing time. Many patients whose extreme nearsightedness places them out of LASIK’s treatable range can have great vision through ICL (implantable collamer lens) surgery, where a corrective lens is implanted into the eye itself – a remarkable procedure that is slightly more invasive than LASIK, but can correct a wider range of prescriptions.
Today’s patient seeking to see the world more clearly, free from glasses and contacts, has more surgical vision correction options than ever before. LASIK is still by far the most commonly performed elective vision correction procedure, and as laser technology continues to advance, it becomes accessible to more and more people. The best way to determine if LASIK, or any other vision correction procedure, is a good option for you, is to contact a surgery provider that is well equipped and experienced in the latest technology.
By Hoopesvision on September 27, 2013
There are many different vision correction options available. When you come to Hoopes Vision for an evaluation, our doctors will help you determine which procedure is best for your unique situation. For some patients, an Implantable Collamer Lens (ICL) is the perfect solution. During this simple outpatient procedure, a soft, small lens is inserted into your eye. The lens works in combination with your natural lens to provide permanent, quality vision. Dr. Robert P. Rivera, a surgeon at Hoopes Vision, is one of the leading ICL surgeons in the world, having implanted more ICLs than any other surgeon in the United States. In this short video, Dr. Rivera discusses the importance of using proper ultrasound measurement of the eye before implanting an ICL.
By Hoopesvision on September 26, 2011
For years, people in Utah have trusted Bill Gephardt’s word. As host of the popular and long-running local KSL TV News segment “Get Gephardt,” he investigated dishonest businesses and service providers, holding them accountable for their actions. Since retiring from active television duty in 2010, he has launched the next phase in his consumer advocacy career: Gephardt Approved. Now, rather than rooting out unscrupulous businesses, he seeks out the best of the best, investigating their business practices and professional reputations thoroughly before declaring them “Gephardt Approved” and backing their services with his own guarantee.
We are proud to announce that Hoopes Vision is the first and only eye surgery center in Utah to be Gephardt Approved, for our achievements in LASIK, cataract surgery, implantable lenses (ICL), and other vision correction procedures. The honor wasn’t bestowed lightly: Bill spent considerable time researching clinical and surgical success rates, interviewing doctors, and visiting our clinic and surgery center on multiple occasions to witness first-hand the level of patient care Hoopes Vision delivers. Only after his thorough investigative process did he declare Hoopes Vision to be Gephardt Approved, profiling our clinic on his website (GephardtApproved.com) and backing us with his well-known guarantee.
Trust is everything when choosing any kind of service provider, but rarely is it as vitally important as in the realm of eye surgery, where you may truly have only one chance to “get it right.” We know that Utah trusts Bill Gephardt, and we’re honored that Bill trusts Hoopes Vision.
By Hoopesvision on June 28, 2011
Hoopes Vision is proud to offer our patients LATISSE®, the 1st and only FDA-approved treatment that grows lashes longer, fuller, and darker.
LATISSE® is a prescribed solution you apply topically to the base of your upper eyelashes once each night. Results come in gradually, starting in as little as 4 weeks and achieving full growth in 16 weeks.
LATISSE® was created by Allergan, a pharmaceutical leader with 60 years of eye care expertise. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication’s active ingredient, bimatoprost, specifically for growing lashes. LATISSE® was approved by the FDA in December of 2008 after undergoing a clinical trial.
The doctors at Hoopes Vision have prescribed LATISSE® to numerous patients, and have been very pleased with the results.
Call us at (801)568-0200 for more information or to schedule an exam with Dr. Yardley to receive a prescription of your own!
By Hoopesvision on June 4, 2011
Hoopes Vision surgeon O. Claron Alldredge, Jr., MD has been called by The Church of Jesus Christ of Latter-day Saints to serve as the President of the historic Salt Lake Temple. We at Hoopes Vision would like to wish him well in his new calling. He will continue practicing through September 2011, at which time he will retire to undertake this full-time calling. We have enjoyed working with such a dedicated, talented surgeon, and look forward to the opportunity to continue caring for his patients. For More details, and a letter from Dr. Alldredge, please open the PDF document below.
By Hoopesvision on February 22, 2011
Dr. Phillip C. Hoopes, Jr. flew to Honduras in February to help render needed cataract surgery for hundreds of visually impaired patients in Honduras. This was his fifth such yearly trip to Honduras to volunteer his surgical skills for these desperate and disadvantaged patients.
Accompanying Dr. Hoopes were Dr. Alan Kozarsky from Atlanta, Georgia, and Dr. Brian Foster. Dr. Kozarsky was Dr. Hoopes’ mentor during his fellowship training in corneal disease and transplantation. Dr. Kozarsky has been traveling to Honduras yearly since 1994 and usually flies his own private plane there. Besides the surgeons, the group brings with them other volunteers who help with the surgeries and patient care.
There are approximately 49,000 people blind from cataracts in Honduras each year. Even with the current levels of charity assistance, the 32 Honduran ophthalmologists capable of performing surgery only are able to remove about 4,000 cataracts per year. More than half of the population of Honduras lives in poverty in rural areas. An estimated one third of Hondurans receive no health care at all. The Honduran health system is so overwhelmed with sickness caused by disease, violence, and infection that ocular health is unfortunately a secondary concern.
More info about this humantarian mission can be found at http://www.operationecho.org/index.html
By Hoopesvision on October 5, 2010
Hoopes Vision announces the addition of O. Claron Alldredge, Jr., MD, Michael J. Bradley, MD, and Thomas P. R. Dutson, OD to our staff of doctors and practice. Both surgeons are fellowship trained in Cornea and External Diseases and specialize in cataract, corneal transplant, and refractive surgery. Optometrist Thomas Dutson has been working with Dr. Alldredge for the last year and now becomes Hoopes Vision’s fifth optometrist.
Dr. Alldredge has been associated with Hoopes Vision since its beginning and has regularly performed surgeries at our on-site ambulatory surgery center, EyeSurg of Utah. Dr. Alldredge is delighted to combine his highly respected Salt Lake City ophthalmology practice with Hoopes Vision’s well known Sandy, Utah vision correction practice. He is one of the most esteemed eye surgeons in the country, and has practiced ophthalmology in Salt Lake City for over 30 years. His patients include many prominent and well know Utahns. His cataract and corneal transplant surgical skills are well respected and he has restored and improved the vision of tens of thousands of patients.
Dr. Michael J. Bradley comes to Hoopes Vision from his fellowship at the University of California-Irvine ophthalmology department. He is also a Utah native and grew up in Holladay. He graduated from the University of Utah School Of Medicine and his residency was taken at the University of Rochester.
Dr. Dutson earned a Bachelor of Science degree from the University of Utah, and then attended Southern California College of Optometry where he received his Doctorate of Optometry with honors. Dr. Dutson is an associate professor of the Pacific University College of Optometry in Portland, Oregon.
Patients looking to improve their vision at any stage of their adult life will find the newest technology paired with the highly skilled and caring doctors at Hoopes Vision. Whether patients are interested in cataract, LASIK or PRK surgery, or other vision correction procedures, our team of doctors will assist you in selecting the best procedure for your individual needs.
To make an appointment to see one of our doctors, please call (801) 568-0200 or (801) 288-0067.
By Hoopesvision on May 17, 2010
Dr. Hoopes was highlighted in the May 2010 edition of Healthy Utah Magazine. The article, titled “An Eye on the Future” discusses the most significant improvements in Ophthalmology including LASIK surgery and multifocal lens implants. It also spotlights Hoopes Vision’s participation in the clinical trial for the Acufocus® Corneal Inlay. The article goes on to list 10 factors contributing to the success of our company over the past 10 years. A copy of this magazine can be picked up in our office or viewed online at www.uthealth.com. Way to go Dr. Hoopes!
Dr. Hoopes, Jr. was previously featured on the cover of Healthy Utah Magazine in March, 2008.